BioCanvas
표적 · PSF1

PSF1 항체

2최다 인용
25인용된 항체
5벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Abcam#ab183524 RRID:AB_2922402 polyclonal
2
cited by
2
Abcam#ab65653 RRID:AB_1142430 polyclonal
0
cited by
3
Novus#H00009837-B02 RRID:AB_2247714 unknown
0
cited by
4
Novus#H00009837-B01 RRID:AB_2294765 unknown
0
cited by
5
Creative Diagnostics#DMAB4576RM RRID:AB_2344712 monoclonal
0
cited by
6
Creative Diagnostics#DPAB-DC1789 RRID:AB_2499108 unknown
0
cited by
7
Bethyl#A304-168A (also A304-168A-T, OWL-A19651) +1 벤더 RRID:AB_2621417 polyclonal
0
cited by
8
Bethyl#A304-169A (also A304-169A-T, OWL-A19652) +1 벤더 RRID:AB_2621418 polyclonal
0
cited by
9
Bethyl#A304-170A (also A304-170A-M, A304-170A-T, OWL-A19653) +1 벤더 RRID:AB_2621419 polyclonal
0
cited by
10
Thermo Fisher Scientific#A304-170A-M (also A304-170A-T) RRID:AB_2781730 polyclonal
0
cited by
11
Novus#NBP2-30365 RRID:AB_3277609 polyclonal
0
cited by
12
Novus#NBP2-30365AF350 RRID:AB_3277610 polyclonal
0
cited by
13
Novus#NBP2-30365AF405 RRID:AB_3277611 polyclonal
0
cited by
14
Novus#NBP2-30365AF488 RRID:AB_3277612 polyclonal
0
cited by
15
Novus#NBP2-30365AF532 RRID:AB_3277613 polyclonal
0
cited by
16
Novus#NBP2-30365AF594 RRID:AB_3277614 polyclonal
0
cited by
17
Novus#NBP2-30365AF647 RRID:AB_3277615 polyclonal
0
cited by
18
Novus#NBP2-30365AF700 RRID:AB_3277616 polyclonal
0
cited by
19
Novus#NBP2-30365AF750 RRID:AB_3277617 polyclonal
0
cited by
20
Novus#NBP2-30365APC RRID:AB_3277618 polyclonal
0
cited by
21
Novus#NBP2-30365B RRID:AB_3277619 polyclonal
0
cited by
22
Novus#NBP2-30365C RRID:AB_3277620 polyclonal
0
cited by
23
Novus#NBP2-30365DL594 RRID:AB_3277621 polyclonal
0
cited by
24
Novus#NBP2-30365F RRID:AB_3277622 polyclonal
0
cited by
25
Novus#NBP2-30365FR RRID:AB_3277623 polyclonal
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

PSF1

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.